Differential penetration of raltegravir throughout gastrointestinal tissueKristine B. Patterson, Angela D. M. Kashuba, Evan S. Dellon et al.|AIDS|2013Cited by 65
A Phenotype–Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/RitonavirJulie B. Dumond, Angela D. M. Kashuba, Kristine B. Patterson et al.|Clinical Pharmacology & Therapeutics|2010Cited by 63
Single- and Multiple-Dose Pharmacokinetics of Darunavir Plus Ritonavir and Etravirine in Semen and Rectal Tissue of HIV-Negative MenKevin C. Brown, Angela D. M. Kashuba, Kristine B. Patterson et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2012Cited by 28
Darunavir, Ritonavir, and Etravirine Pharmacokinetics in the Cervicovaginal Fluid and Blood Plasma of HIV-Infected WomenKristine B. Patterson, Angela D. M. Kashuba, Steven H. Jennings et al.|Antimicrobial Agents and Chemotherapy|2010Cited by 18
Single- and Multiple-Dose Pharmacokinetics of Darunavir Plus Ritonavir and Etravirine in Semen and Rectal Tissue of HIV-Negative MenMelissa Spacek, Myron S. Cohen, Kevin C. Brown et al.|UNC Libraries|2020Cited by 0